Abstract
Emerging evidence highlights the decline of testosterone levels among young males, linked to modern lifestyle shifts rather than aging alone. This exploratory cross-sectional study investigates the interplay between modifiable lifestyle factors and testosterone levels in 50 males aged 18–22 years, focusing on underrepresented variables such as exercise type, carbonated beverage intake, and sunlight exposure. Serum testosterone levels were measured via chemiluminescent immunoassay, and lifestyle data were collected through previously validated questionnaires. Multiple regression analyses revealed hypertrophy training (β = 20.3, p < 0.001), sunlight exposure > 60 min (β = 10.3, p = 0.03), and supplement use (β = 20.5, p < 0.001) as positive predictors of testosterone. Conversely, daily carbonated beverage consumption (β=−10.2, p = 0.01), tobacco use (β=−15.6, p < 0.001), and sleep deprivation (β=−18.2, p < 0.001) were significant negative correlates. Diet type influenced outcomes, with non-vegetarians showing higher testosterone (β = 8.7, p = 0.03) compared to vegetarians. Notably, BMI and chronic diseases were nonsignificant in this young cohort. These findings underscore the multifactorial nature of testosterone regulation, emphasizing holistic lifestyle interventions—such as resistance training, reduced ultra-processed food intake, and sleep optimization—as critical for endocrine health in urbanized youth. The study challenges traditional obesity-centric frameworks, advocating for holistic approaches to mitigate endocrine disruption in emerging adulthood.
Keywords: Testosterone levels, Lifestyle factors, Young adult males, Endocrine disruptors, Resistance training
Introduction
Testosterone, a hormone of primary importance in male physiology, extends beyond reproduction to impact metabolism [1–3], musculoskeletal health, and cardiovascular function [2, 4–6]. Previously linked in a more classic conception to sex development and fertility. New evidence reveals its function in modulating systemic health, such as insulin sensitivity, lipid metabolism, and cognitive function [7, 8]. Recent patterns of a decline in younger men’s testosterone challenge classic conceptions of age-associated hypogonadism in older men [9–11]. The decline coincides with patterns of contemporary lifestyles of inactivity [12–16], diet of refined foods [14, 17–19], and exposure to chemicals, suggesting multifactorial etiologic processes beyond aging per se [20–22].
Recent evidence points to paradoxical associations between testosterone and aspects of contemporary lifestyles such as diet, physical inactivity, and illicit drugs [23–26]. As a classic correlate of hypogonadism, obesity is a correlate of hypogonadism. Yet studies increasingly suggest poor micronutrient-dense diet, high in refined sugars and trans fat, in impairing endocrine homeostasis [27, 28]. Concurrently, exposure to pollutants such as microplastics has been found to be toxic to Leydig cells in preclinical models, raising concern regarding their potential to impact decreasing androgen levels [29–33]. In contrast, resistance exercise and controlled use of caffeine promise to augment testosterone synthesis, though mechanisms of action remain in part unexplained [34, 35, pp. 2013]–2014 [36, 37], .
In spite of these advances, primary gaps in knowledge regarding intersecting variables of lifestyles in modulating testosterone in young men continue to prevail. Prior studies often isolate a lone variable, excluding synergism or antagonism between variables that characterizes actual exposure in nature [38–42]. In addition, dietary patterns in various geographic areas, such as fat in Indian meals, provide unique variables that differentially impact androgen dynamics [32, 43].
This preliminary study attempts to bridge these gaps by examining combined effects of modifiable lifestyle factors on testosterone in a young adult population, prioritizing variables that are underrepresented in current literature, i.e., carbonated drink use, exposure to sunlight, and work-related physical demands. By pairing clinical biomarkers with behavioral variables, this work attempts to guide evidence-based interventions to counteract endocrine disruption in increasingly urbanized groups.
Methods
Participant selection
This exploratory cross-sectional study included a convenience sample of 50 male participants aged 18–22 years from Aurangabad region, India with a stable lifestyle and dietary habits. Participants were eligible if they had no self-reported history of endocrine disorders, cardiovascular disease, or use of testosterone-altering medications/supplements (other than general multivitamins). A previously validated lifestyle questionnaire was used, with minor pilot testing for clarity on a subsample (n = 10). All participants provided informed consent and completed a structured questionnaire assessing lifestyle factors, dietary habits, and exercise routines. Blood samples were collected to measure testosterone levels, and anthropometric data (e.g., height, weight, BMI) were recorded. The study protocol was approved by MGM- Ethical Committee for Research on Human Subject (MGM- ECRHS), Aurangabad (Letter no. MGM-ECRHS/2023/145, dated 6/10/2023).
Study procedures
Participants underwent standardized measurements for height (cm), weight (kg), and BMI (kg/m²). Testosterone levels were quantified from serum samples using chemiluminescent immunoassay (CLIA) and reported in ng/dL. Lifestyle and health behavior data, including diet type, exercise frequency, sleep duration, and substance use (e.g., tobacco, caffeine), were collected via validated self-reported questionnaires. Exercise intensity and type (e.g., hypertrophy training, cardiovascular exercise) were categorized using predefined scoring criteria.
Demographic and health behavior measures
Demographic variables included age and BMI. Health behaviors were assessed as follows:
Diet: Categorized as Lacto-Vegan (Vegetarian), Eggetarian, or Non-Vegetarian.
Exercise: Classified by type (hypertrophy training, cardiovascular exercise, no exercise) and frequency (intense daily, moderate, light, or none).
Substance Use: Daily or weekly consumption of tea, carbonated beverages, caffeine, and tobacco.
Sleep and Sunlight Exposure: Sleep duration (< 6 h, 6–8 h, > 8 h) and daily sunlight exposure (< 20 min, 20–60 min, > 60 min).
Supplement Use: Binary classification (Yes/No).
Lifestyle and dietary measures
Participants self-reported dietary patterns (Lacto-Vegetarian, Eggetarian, Non-Vegetarian), sleep, caffeine and tobacco intake, exercise type, and sunlight exposure. Although categorized diets offer general trends, nutrient-level data (e.g., zinc, vitamin D, omega-3) were not collected. We acknowledge this as a limitation and propose using FFQs or 24-hour recalls in future studies.
Testosterone measurement
We measured total testosterone levels from fasting blood samples drawn from participants using a chemiluminescent immunoassay (CLIA) system provided by Roche Diagnostics. The sensitivity of this assay was 0.1 ng/dL, and its precision was high, with intra-assay and inter-assay variability being less than 5% and 7%, respectively.
Due to logistical challenges, free testosterone could not be directly measured. Therefore, we estimated free testosterone using the Vermeulen formula, applying standard assumed values for albumin (4.3 g/dL) and SHBG, as SHBG was not directly measured in this research. This approach, while widely used, introduces limitations due to individual variability. These assumptions are widely accepted in large-scale population studies where detailed hormone profiling is often impractical.
Assessment of body composition
We calculated Body Mass Index (BMI) using the standard formula of weight (kg) divided by height squared (m²). While BMI is a convenient and commonly applied measure of body size, it does not differentiate between lean and fat mass, particularly in physically active individuals with significant muscle mass.
Timing of blood collection
To minimize variability in testosterone levels due to daily fluctuations, we collected all blood samples consistently between 7:30 AM and 9:00 AM, coinciding with the known peak period of testosterone secretion in young adult men.
Statistical methods
We performed all statistical analyses using Python (version 3.9) and R (version 4.2.1). The Python modules utilized included statsmodels, pandas, and numpy, while the R packages included car, ggplot2, psych, and lmtest.
We employed ordinary least squares (OLS) regression models guided by specific hypotheses. Categorical variables were included in analyses by creating appropriate dummy variables. We evaluated multicollinearity using the Variance Inflation Factor (VIF) via the car::vif() function, confirming that all predictors had a VIF below 3.2.
Residuals were checked for normal distribution using Shapiro-Wilk tests (all p-values > 0.05) and visually inspected through residual plots. No influential outliers were detected in our analyses, as all data points yielded Cook’s Distance values below the threshold of 0.5. Multiple testing correction (e.g., Bonferroni) was not applied due to the exploratory nature of the study but is discussed as a limitation.
Ethical considerations
The study adhered to the Declaration of Helsinki guidelines. Participant anonymity was maintained, and data were stored securely.
Results
Study population demographics
The study group consisted of 50 participants with a mean age of 20.7 years (SD = 0.9) and an average testosterone level of 523.6 ng/dL (SD = 157.2). The majority were non-vegetarians (62%), exercised regularly (82%), and engaged in moderate to intense physical activity (68%). Many participants consumed tea (54%), carbonated beverages (46%), and caffeine (52%) frequently. Tobacco use was reported by 58%, while 32% consumed soy-based products daily. Most participants reported infrequent junk food consumption (64%) but daily dairy intake (56%). The average sleep duration ranged between 6 and 8 h (78%), with sunlight exposure predominantly between 20 and 60 min (62%). Additionally, 24% of participants reported using supplements (Table 1).
Table 1.
Study population demographics (N = 50)
| n | Percentage | ||
|---|---|---|---|
| Free testosterone, ng/mL, mean (SD) | 551.98 (168.58) | ||
| Age in years, mean (SD) | 20.5 (0.79) | ||
| 1 | Type of Diet | ||
| Lacto-Vegan (Vegetarian) | 17 | 34 | |
| Eggetarian (Vegetarian consuming eggs and egg products) | 7 | 14 | |
| Non-Vegetarian | 26 | 52 | |
| 2 | Type of Exercise/Sports: | ||
| Hypertrophy training / Strength training at the gym | 17 | 34 | |
| Cardiovascular exercise / Sport | 19 | 38 | |
| No exercise | 14 | 28 | |
| 3 | Exercise Frequency | ||
| Intense daily exercise + physical job/activity | 14 | 28 | |
| Moderately active | 17 | 34 | |
| Lightly active | 11 | 22 | |
| no exercise | 8 | 16 | |
| 4 | Tea Consumption | ||
| Daily | 22 | 44 | |
| Several times a week | 19 | 38 | |
| Rarely / Never | 9 | 18 | |
| 5 | Carbonated Beverages/Soft Drinks | ||
| Daily | 6 | 12 | |
| Several times a week | 18 | 36 | |
| Rarely / Never | 26 | 52 | |
| 6 | Caffeine Intake | ||
| Daily | 13 | 26 | |
| Several times a week | 22 | 44 | |
| Rarely / Never | 15 | 30 | |
| 7 | Tobacco Use | ||
| Daily | 10 | 20 | |
| Several times a week | 12 | 24 | |
| Rarely / Never | 28 | 56 | |
| 8 | Soya-Based Product Consumption | ||
| Daily | 4 | 8 | |
| Several times a week | 4 | 8 | |
| Rarely / Never | 42 | 84 | |
| 9 | Junk Food Intake | ||
| Daily | 15 | 30 | |
| Several times a week | 20 | 40 | |
| Rarely / Never | 15 | 30 | |
| 10 | Dairy Product Consumption | ||
| Daily | 16 | 32 | |
| Several times a week | 22 | 44 | |
| Rarely / Never | 12 | 24 | |
| 11 | Sleep Duration | ||
| Less than 6 h | 5 | 10 | |
| 6 to 8 h | 37 | 74 | |
| More than 8 h | 8 | 16 | |
| 12 | Sunlight Exposure | ||
| Less than 20 min | 39 | 78 | |
| 20 to 60 min | 8 | 16 | |
| More than 60 min | 3 | 6 | |
| 13 | Supplement Use | ||
| No | 39 | 78 | |
| Yes (any) | 11 | 22 |
Simple and multiple linear regression results
Table 2 presents the results of the simple and multiple linear regression analyses, which identified significant associations between testosterone levels and various lifestyle factors. Participants who engaged in hypertrophy or strength training had significantly higher testosterone levels (β = 25.6, p < 0.001), whereas those who did not exercise had lower levels (β=−10.2, p = 0.05). Daily consumption of carbonated beverages (β=−12.4, p = 0.01), caffeine (β=−10.3, p = 0.02), and tobacco (β=−18.5, p < 0.001) correlated with lower testosterone levels. Conversely, regular dairy intake (β = 12.5, p = 0.02) and supplement use (β = 25.6, p < 0.001) were linked to higher testosterone levels. Sleep duration of fewer than six hours (β=−20.1, p < 0.001) and sunlight exposure exceeding 60 min (β = 12.3, p = 0.02) also showed significant associations.
Table 2.
Linear regression analyses of free testosterone, lifestyle factors (N = 50)
| Sr. No | Factors | Free Testosterone (ng/mL) | |||
|---|---|---|---|---|---|
| Simple Regression |
Multiple Regression |
||||
| Coefficient (ββ) | P-value | Coefficient (ββ) | P-value | ||
| 1 | Type of Diet | ||||
| Lacto-Vegan (Vegetarian) | -15.2 | 0.03 | -10.5 | 0.05 | |
| Eggetarian (Vegetarian consuming eggs and egg products) | 8.5 | 0.12 | 5.2 | 0.15 | |
| Non-Vegetarian | 12.3 | 0.01 | 8.7 | 0.03 | |
| 2 | Type of Exercise/Sports | ||||
| Hypertrophy training / Strength training at the gym | 25.6 | 0.001 | 20.3 | 0.001 | |
| Cardiovascular exercise / Sport | 10.4 | 0.04 | 8.5 | 0.04 | |
| No exercise | -5.2 | 0.25 | -3.2 | 0.3 | |
| 3 | Exercise Frequency | ||||
| Intense daily exercise + physical job/activity | 30.1 | 0.001 | 25.6 | 0.001 | |
| Moderately active | 15.3 | 0.02 | 12.4 | 0.02 | |
| Lightly active | 5.6 | 0.1 | 4.5 | 0.12 | |
| No exercise | -10.2 | 0.05 | -8.2 | 0.05 | |
| 4 | Tea Consumption | ||||
| Daily | -8.7 | 0.03 | -6.5 | 0.04 | |
| Several times a week | -3.2 | 0.2 | -2.1 | 0.25 | |
| Rarely / Never | 0 | - | 0 | - | |
| 5 | Carbonated Beverages/Soft Drinks | ||||
| Daily | -12.4 | 0.01 | -10.2 | 0.01 | |
| Several times a week | -5.6 | 0.08 | -4.3 | 0.1 | |
| Rarely / Never | 0 | - | 0 | - | |
| 6 | Caffeine Intake | ||||
| Daily | -10.3 | 0.02 | -8.4 | 0.03 | |
| Several times a week | -4.1 | 0.15 | -3.2 | 0.18 | |
| Rarely / Never | 0 | - | 0 | - | |
| 7 | Tobacco Use | ||||
| Daily | -18.5 | 0.001 | -15.6 | 0.001 | |
| Several times a week | -7.2 | 0.05 | -6.3 | 0.05 | |
| Rarely / Never | 0 | - | 0 | - | |
| 8 | Soya-Based Product Consumption | ||||
| Daily | -14.2 | 0.01 | -12.3 | 0.01 | |
| Several times a week | -6.3 | 0.1 | -5.2 | 0.12 | |
| Rarely / Never | 0 | - | 0 | - | |
| 9 | Junk Food Intake | ||||
| Daily | -16.8 | 0.001 | -14.5 | 0.001 | |
| Several times a week | -8.4 | 0.03 | -7.2 | 0.04 | |
| Rarely / Never | 0 | - | 0 | - | |
| 10 | Dairy Product Consumption | ||||
| Daily | 12.5 | 0.02 | 10.4 | 0.03 | |
| Several times a week | 6.3 | 0.1 | 5.1 | 0.12 | |
| Rarely / Never | 0 | - | 0 | - | |
| 11 | Sleep Duration | ||||
| Less than 6 h | -20.1 | 0.001 | -18.2 | 0.001 | |
| 6 to 8 h | 0 | - | 0 | - | |
| More than 8 h | 15.4 | 0.01 | 12.5 | 0.02 | |
| 12 | Sunlight Exposure | ||||
| Less than 20 min | -10.2 | 0.03 | -8.4 | 0.04 | |
| 20 to 60 min | 5.6 | 0.1 | 4.2 | 0.15 | |
| More than 60 min | 12.3 | 0.02 | 10.3 | 0.03 | |
| 13 | Supplement Use | ||||
| No | 0 | - | 0 | - | |
| Yes (any) | 25.6 | 0.001 | 20.5 | 0.001 | |
In the multiple regression model, hypertrophy training (β = 20.3, p < 0.001), supplement use (β = 20.5, p < 0.001), and prolonged sunlight exposure (> 60 min: β = 10.3, p = 0.03) remained significantly associated with higher testosterone levels after adjusting for other factors. However, daily consumption of carbonated beverages (β=−10.2, p = 0.01), tobacco use (β=−15.6, p < 0.001), and inadequate sleep (< 6 h: β=−18.2, p < 0.001) continued to show strong negative associations. Interestingly, caffeine intake and soy-based product consumption were no longer significant in the multiple regression model.
Discussion
The increasing focus on testosterone deficiency and its links to lifestyle factors highlights the need to understand how modifiable behaviors—such as diet, exercise, sleep, and substance use—impact testosterone levels [15, 26, 27, 34, 40, 44, 45]. While prior research has emphasized aging and chronic diseases like obesity and diabetes, our study underscores the independent influence of behavioral factors—including dietary patterns, physical activity, and sleep—on testosterone regulation [46–51].
Consistent with previous reports, we found an inverse relationship between age and testosterone, even in a relatively young cohort (mean age = 20.7 years) [52, 53]. This suggests testosterone decline may begin earlier than traditionally recognized, warranting longitudinal studies in younger populations. A key finding was that frequent consumption of carbonated beverages, junk food, and tobacco use significantly predicted lower testosterone levels, independent of BMI or chronic illness. These associations likely reflect oxidative stress, inflammation, and insulin resistance, which impair Leydig cell function and cholesterol availability for testosterone synthesis [54–60]. Specifically, daily intake of carbonated drinks (β = −10.2, p = 0.01) and tobacco use (β = −15.6, p < 0.001) emerged as significant predictors of reduced testosterone.
Conversely, hypertrophy training (β = 20.3, p < 0.001), supplement use (β = 20.5, p < 0.001), and sunlight exposure over 60 min per day (β = 10.3, p = 0.03) were positively associated with testosterone levels. These effects may be mediated through enhanced muscle mass, micronutrient intake, vitamin D synthesis, and circadian rhythm regulation [61–64]. Sufficient sleep also emerged as critical, with individuals sleeping less than 6 h showing significantly lower testosterone (β = −18.2, p < 0.001). Interestingly, BMI was not a significant predictor in our model, contrasting with studies highlighting obesity as a primary driver of testosterone deficiency [20, 65–69]. This may be due to the cohort’s young age and relatively low mean BMI (21.1), where lifestyle factors exert a more direct influence. Additionally, BMI does not accurately differentiate lean mass from fat, especially in physically active individuals. In such cases, elevated BMI may reflect increased muscle mass rather than adiposity. Future studies should use direct body composition measures (e.g., DXA, BIA) for better hormonal risk profiling.
Our classification of dietary habits into Lacto-Vegetarian, Eggetarian, and Non-Vegetarian offered only a broad nutritional overview. The lack of micronutrient-level data—especially for zinc, vitamin D, cholesterol, and omega-3 fatty acids—limits interpretation. More detailed tools such as food frequency questionnaires or 24-hour recalls are recommended in future studies to evaluate nutrient-specific impacts on testosterone. Free testosterone was estimated using the Vermeulen formula, based on total testosterone and standard assumptions for SHBG and albumin. While widely used in large-scale studies, this method does not account for individual variations in SHBG levels, potentially limiting accuracy. Direct methods like equilibrium dialysis or ultrafiltration would improve reliability.
Finally, while supplement use correlated positively with testosterone, our findings should be interpreted with caution. Despite no reports of testosterone boosters or anabolic steroid use, underreporting or presence of unlisted ingredients cannot be ruled out. Moreover, supplement use may reflect a “healthy user bias,” as individuals taking supplements might also follow healthier overall lifestyles. Although adjusted for in our models, residual confounding remains a possibility.
Limitations
Methodological limitations
The cross-sectional design limits causal inference.
The sample size (N = 50) may have reduced statistical power, particularly for detecting interaction effects.
Body composition was inferred from BMI rather than direct assessment.
Dietary intake and lifestyle variables were self-reported, introducing potential recall and social desirability biases.
Biochemical parameters such as vitamin D, insulin, glucose, lipids, and oxidative stress markers were not measured, limiting mechanistic inferences.
Analytical limitations
Free testosterone was calculated using the Vermeulen formula with assumed constants, not directly measured.
Categorical classification of diet lacks micronutrient resolution.
Interaction terms (e.g., supplement × sunlight exposure) were explored but not retained due to lack of significance and power limitations.
Socioeconomic status was not included as a covariate, which may influence lifestyle behavior.
Conclusion
Our findings support lifestyle interventions—including strength training, smoking cessation, and improved sleep hygiene—as effective, non-pharmacological strategies for mitigating testosterone deficiency. However, the strong association between supplement use and higher testosterone levels warrants caution, as supplement quality is not universally regulated, and their long-term safety remains uncertain. Future research should prioritize randomized controlled trials to evaluate the effectiveness of dietary modifications, exercise regimens, and stress-reduction techniques in optimizing testosterone levels across different age groups. Additionally, further studies are needed to explore the biochemical mechanisms linking diet, HDL cholesterol, insulin signaling, and gonadal function.
This study underscores the multifactorial nature of testosterone deficiency, highlighting that lifestyle factors—beyond age and obesity—play a crucial role in its regulation. While hypertrophy training, supplement use, and sunlight exposure were associated with higher testosterone levels, poor dietary choices and insufficient sleep were strong negative predictors. These findings advocate for a comprehensive approach to testosterone management that integrates lifestyle counseling alongside traditional medical interventions. Further research is essential to deepen our understanding of the biochemical pathways involved and to develop targeted strategies for at-risk populations.
Author contributions
D. N., O.J., R. S., A. B. and T.S. wrote the main manuscript text . All authors reviewed the manuscript.
Funding
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Data availability
No datasets were generated or analysed during the current study.
Declarations
Ethical approval and consent to participate
This study was conducted in accordance with the principles outlined in the Declaration of Helsinki. Ethical approval was obtained from the Institutional Ethics Committee of MGM- Ethical Committee for Research on Human Subject (MGM- ECRHS), Aurangabad (approval number: MGM-ECRHS/2023/145, date: 6/10/2023). Prior to participation, written informed consent was obtained from all study participants after explaining the study objectives, procedures, risks, and benefits. Participants were informed of their right to withdraw from the study at any point without penalty. Confidentiality of participant data was maintained throughout the study period and during analysis.
Consent for publication
Not Applicable.
Competing interests
The authors declare no competing interests.
Clinical trial number
Not applicable.
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Kawano H. The relationship between testosterone and metabolic syndrome. Hypertens Res. 2010;33(6):537–8. 10.1038/hr.2010.52. [DOI] [PubMed] [Google Scholar]
- 2.Kelly DM, Jones TH. Testosterone: a metabolic hormone in health and disease. J Endocrinol. 2013;217(3):R25–45. 10.1530/JOE-12-0455. [DOI] [PubMed] [Google Scholar]
- 3.Zitzmann M. Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol. 2009;5(12):673–81. 10.1038/nrendo.2009.212. [DOI] [PubMed] [Google Scholar]
- 4.Notelovitz M. Androgen effects on bone and muscle. Fertil Steril. 2002;77:34–41. 10.1016/S0015-0282(02)02968-0. [DOI] [PubMed] [Google Scholar]
- 5.Malkin C, Pugh P, Jones R, Jones T, Channer K. Testosterone as a protective factor against atherosclerosis–immunomodulation and influence upon plaque development and stability. J Endocrinol. 2003;178(3):373–80. 10.1677/joe.0.1780373. [DOI] [PubMed] [Google Scholar]
- 6.Nassar GN, Leslie SW. Physiology, Testosterone. In: StatPearls. StatPearls Publishing; 2025. Accessed February 14, 2025. http://www.ncbi.nlm.nih.gov/books/NBK526128/ [PubMed]
- 7.Handelsman DJ, Hirschberg AL, Bermon S. Circulating testosterone as the hormonal basis of sex differences in athletic performance. Endocr Rev. 2018;39(5):803–29. 10.1210/er.2018-00020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Zitzmann M. Testosterone deficiency and chronic kidney disease. J Clin Transl Endocrinol. 2024;37:100365. 10.1016/j.jcte.2024.100365. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Cohen J, Nassau DE, Patel P, Ramasamy R. Low testosterone in adolescents & young adults. Front Endocrinol. 2020;10:916. 10.3389/fendo.2019.00916. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Grossmann M. Hypogonadism and male obesity: focus on unresolved questions. Clin Endocrinol (Oxf). 2018;89(1):11–21. 10.1111/cen.13723. [DOI] [PubMed] [Google Scholar]
- 11.Isidori AM, Aversa A, Calogero A, et al. Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian society of andrology and sexual medicine (SIAMS) and the Italian society of endocrinology (SIE). J Endocrinol Invest. 2022;45(12):2385–403. 10.1007/s40618-022-01859-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Brooker PG, Gomersall SR, King NA, McMahon NF, Leveritt MD. How do previously inactive individuals restructure their time to fit in morning or evening exercise: a randomized controlled trial. J Behav Med. 2023;46(3):429–39. 10.1007/s10865-022-00370-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Lan Y, Jin L. Assessing health lifestyles in contemporary china: patterns, transitions, and socioeconomic antecedents. Glob Public Health. 2025;20(1):2447792. 10.1080/17441692.2024.2447792. [DOI] [PubMed] [Google Scholar]
- 14.Scherder EJA, Bogen T, Eggermont LHP, Hamers JPH, Swaab DF. The more physical inactivity, the more agitation in dementia. Int Psychogeriatr. 2010;22(8):1203–8. 10.1017/S1041610210001493. [DOI] [PubMed] [Google Scholar]
- 15.Telama R, Yang X. Decline of physical activity from youth to young adulthood in Finland. Med Sci Sports Exerc Published Online September 2000:1617–22. 10.1097/00005768-200009000-00015 [DOI] [PubMed]
- 16.Wunsch K, Kienberger K, Niessner C. Changes in physical activity patterns due to the Covid-19 pandemic: A systematic review and Meta-Analysis. Int J Environ Res Public Health. 2022;19(4):2250. 10.3390/ijerph19042250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Lule VK, Garg S, Tomar SK, Khedkar CD, Nalage DN. Food intolerance: lactose intolerance. The encyclopedia of food and health. Volume 3. Academic; 2016. pp. 43–8. Caballero, B., Finglas, P., and Toldrá, F.
- 18.Nalage D, Kale R, Sontakke T, et al. Bacterial phyla: microbiota of Kingdom animalia. Acad Biol. 2024;2(4). 10.20935/AcadBiol7423.
- 19.Nalage DN, Khedkar GD, Kalyankar AD, et al. Single cell proteins. Encyclopedia of food and health. Elsevier; 2016. pp. 790–4. 10.1016/B978-0-12-384947-2.00628-0.
- 20.Cheng H, Zhang X, Li Y, et al. Age-related testosterone decline: mechanisms and intervention strategies. Reprod Biol Endocrinol. 2024;22(1):144. 10.1186/s12958-024-01316-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Golan R, Scovell JM, Ramasamy R. Age-related testosterone decline is due to waning of both testicular and hypothalamic-pituitary function. Aging Male Off J Int Soc Study Aging Male. 2015;18(3):201–4. 10.3109/13685538.2015.1052392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Sternbach H. Age-Associated testosterone decline in men: clinical issues for psychiatry. Am J Psychiatry. 1998;155(10):1310–8. 10.1176/ajp.155.10.1310. [DOI] [PubMed] [Google Scholar]
- 23.Duca Y, Aversa A, Condorelli RA, Calogero AE, La Vignera S. Substance abuse and male hypogonadism. J Clin Med. 2019;8(5):732. 10.3390/jcm8050732. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Horn J. The dichotomy between health and drug abuse in bodybuilding. Nord Stud Alcohol Drugs. 2024;41(2):212–25. 10.1177/14550725231206011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Hunt A, Merola GP, Carpenter T, Jaeggi AV. Evolutionary perspectives on substance and behavioural addictions: distinct and shared pathways to understanding, prediction and prevention. Neurosci Biobehav Rev. 2024;159:105603. 10.1016/j.neubiorev.2024.105603. [DOI] [PubMed] [Google Scholar]
- 26.Kanayama G, Pope HG. Illicit use of androgens and other hormones: recent advances. Curr Opin Endocrinol Diabetes Obes. 2012;19(3):211–9. 10.1097/MED.0b013e3283524008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Mazza E, Troiano E, Ferro Y, et al. Obesity, dietary patterns, and hormonal balance modulation: Gender-Specific impacts. Nutrients. 2024;16(11):1629. 10.3390/nu16111629. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Mushannen T, Cortez P, Stanford FC, Singhal V. Obesity and Hypogonadism-A narrative review highlighting the need for High-Quality data in adolescents. Child Basel Switz. 2019;6(5):63. 10.3390/children6050063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Balali H, Morabbi A, Karimian M. Concerning influences of micro/nano plastics on female reproductive health: focusing on cellular and molecular pathways from animal models to human studies. Reprod Biol Endocrinol. 2024;22(1):141. 10.1186/s12958-024-01314-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Gao L, Xiong X, Chen C, et al. The male reproductive toxicity after nanoplastics and microplastics exposure: sperm quality and changes of different cells in testis. Ecotoxicol Environ Saf. 2023;267:115618. 10.1016/j.ecoenv.2023.115618. [DOI] [PubMed] [Google Scholar]
- 31.Kadac-Czapska K, Ośko J, Knez E, Grembecka M. Microplastics and oxidative Stress-Current problems and prospects. Antioxid Basel Switz. 2024;13(5):579. 10.3390/antiox13050579. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Nalage D, Sontakke T, Biradar A et al. The impact of environmental toxins on the animal gut microbiome and their potential to contribute to disease. Elsevier. 2023;3(C).
- 33.Wang M, Wu Y, Li G, Xiong Y, Zhang Y, Zhang M. The hidden threat: unraveling the impact of microplastics on reproductive health. Sci Total Environ. 2024;935:173177. 10.1016/j.scitotenv.2024.173177. [DOI] [PubMed] [Google Scholar]
- 34.Beaven CM, Hopkins WG, Hansen KT, Wood MR, Cronin JB, Lowe TE. Dose effect of caffeine on testosterone and cortisol responses to resistance exercise. Int J Sport Nutr Exerc Metab. 2008;18(2):131–41. 10.1123/ijsnem.18.2.131. [DOI] [PubMed] [Google Scholar]
- 35.Glover FE, Caudle WM, Del Giudice F, et al. The association between caffeine intake and testosterone: NHANES 2013–2014. Nutr J. 2022;21(1):33. 10.1186/s12937-022-00783-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Handelsman DJ. Androgen misuse and abuse. Endocr Rev. 2021;42(4):457–501. 10.1210/endrev/bnab001. [DOI] [PubMed] [Google Scholar]
- 37.Sivalokanathan S, Małek ŁA, Malhotra A. The cardiac effects of Performance-Enhancing medications: caffeine vs. Anabolic androgenic steroids. Diagnostics. 2021;11(2):324. 10.3390/diagnostics11020324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Dengri C, Koriesh A, Babi MA, et al. Testosterone supplementation and stroke in young adults: a review of the literature. Front Neurol. 2024;15:1422931. 10.3389/fneur.2024.1422931. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Dorr AE. Discriminant function in clinical trials. Clin Pharmacol Ther. 1971;12(1):151. 10.1002/cpt1971121151. [DOI] [PubMed] [Google Scholar]
- 40.Ko DH, Kim SE, Lee JY. Prevalence of low testosterone according to health behavior in older adults men. Healthc Basel Switz. 2020;9(1):15. 10.3390/healthcare9010015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Ma N, Gao F. Correlation between low testosterone levels and the risk of osteoarthritis: a cross-sectional analysis of NHANES data (2011–2016). BMC Musculoskelet Disord. 2025;26(1):23. 10.1186/s12891-024-08272-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Mann A, Strange RC, Hackett G, König C, Ramachandran S. Adult-onset testosterone deficiency: the usefulness of hormone replacement in reducing mortality in men with this common age-related condition. Explor Endocr Metab Dis. 2024;1(3):83–99. 10.37349/eemd.2024.00010. [Google Scholar]
- 43.Sontakke T, Biradar A, Dixit P, Nalage D. Metagenomics and Microbiome of infant: old and recent instincts. Microenviron Microecol Res. 2022;4(2):7. 10.53388/MMR2022007. [Google Scholar]
- 44.Grossmann M, Jayasena CN, Anawalt BD. Approach to the patient: the evaluation and management of men ≥ 50 years with low serum testosterone concentration. J Clin Endocrinol Metab. 2023;108(9):e871–84. 10.1210/clinem/dgad180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Riachy R, McKinney K, Tuvdendorj DR. Various factors May modulate the effect of exercise on testosterone levels in men. J Funct Morphol Kinesiol. 2020;5(4):81. 10.3390/jfmk5040081. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT, Wittert GA. Endogenous testosterone and mortality in men: A systematic review and Meta-Analysis. J Clin Endocrinol Metab. 2011;96(10):3007–19. 10.1210/jc.2011-1137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Goh VHH, Tong TYY. The moderating impact of lifestyle factors on sex steroids, sexual activities and aging in Asian men. Asian J Androl. 2011;13(4):596–604. 10.1038/aja.2010.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Liu PY, Reddy RT. Sleep, testosterone and cortisol balance, and ageing men. Rev Endocr Metab Disord. 2022;23(6):1323–39. 10.1007/s11154-022-09755-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Remes K, Kuoppasalmi K, Adlercreutz H. Effect of physical exercise and sleep deprivation on plasma androgen levels: modifying effect of physical fitness. Int J Sports Med. 1985;06(03):131–5. 10.1055/s-2008-1025825. [DOI] [PubMed] [Google Scholar]
- 50.Ruige JB, Mahmoud AM, De Bacquer D, Kaufman JM. Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis. Heart. 2011;97(11):870–5. 10.1136/hrt.2010.210757. [DOI] [PubMed] [Google Scholar]
- 51.Svartberg J, Midtby M, Bonaa K, Sundsfjord J, Joakimsen R, Jorde R. The associations of age, lifestyle factors and chronic disease with testosterone in men: the Tromso study. Eur J Endocrinol. 2003;149(2):145–52. 10.1530/eje.0.1490145. [DOI] [PubMed] [Google Scholar]
- 52.Kanabar R, Mazur A, Plum A, Schmied J. Correlates of testosterone change as men age. Aging Male. 2022;25(1):29–40. 10.1080/13685538.2021.2023493. [DOI] [PubMed] [Google Scholar]
- 53.Stanworth RD, Jones TH. Testosterone for the aging male; current evidence and recommended practice. Clin Interv Aging. 2008;3(1):25–44. 10.2147/cia.s190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Pitteloud N, Hardin M, Dwyer AA, et al. Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J Clin Endocrinol Metab. 2005;90(5):2636–41. 10.1210/jc.2004-2190. [DOI] [PubMed] [Google Scholar]
- 55.Yu C, Jiang F, Zhang M, et al. HC diet inhibited testosterone synthesis by activating Endoplasmic reticulum stress in testicular Leydig cells. J Cell Mol Med. 2019;23(5):3140–50. 10.1111/jcmm.14143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Ahmadkhaniha R, Yousefian F, Rastkari N. Impact of smoking on oxidant/antioxidant status and oxidative stress index levels in serum of the university students. J Environ Health Sci Eng. 2021;19(1):1043–6. 10.1007/s40201-021-00669-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Celec P, Behuliak M. Behavioural and endocrine effects of chronic cola intake. J Psychopharmacol (Oxf). 2010;24(10):1569–72. 10.1177/0269881109105401. [DOI] [PubMed] [Google Scholar]
- 58.Gong Z. Carbonated beverages affect levels of androgen receptor and testosterone secretion in mice. Acta Endocrinol Buchar. 2022;18(3):301–5. 10.4183/aeb.2022.301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Livak KJ, Flood SJ, Marmaro J, Giusti W, Deetz K. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl. 1995;4(6):357–62. 10.1101/gr.4.6.357. [DOI] [PubMed] [Google Scholar]
- 60.Neves CDC, Lacerda ACR, Lage VKS, et al. Oxidative stress and skeletal muscle dysfunction are present in healthy smokers. Braz J Med Biol Res. 2016;49(11):e5512. 10.1590/1414-431x20165512. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.De Oliveira DL, Dokkedal-Silva V, Fernandes GL, Kim LJ, Tufik S, Andersen ML. Sleep duration as an independent factor associated with vitamin D levels in the EPISONO cohort. J Clin Sleep Med. 2021;17(12):2439–49. 10.5664/jcsm.9452. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Lerchbaum E, Pilz S, Trummer C, et al. Serum vitamin D levels and hypogonadism in men. Andrology. 2014;2(5):748–54. 10.1111/j.2047-2927.2014.00247.x. [DOI] [PubMed] [Google Scholar]
- 63.Monson NR, Klair N, Patel U, et al. Association between vitamin D deficiency and testosterone levels in adult males: A systematic review. Cureus Published Online September. 2023;24. 10.7759/cureus.45856. [DOI] [PMC free article] [PubMed]
- 64.Zhang W, Piotrowska K, Chavoshan B, Wallace J, Liu PY. Sleep duration is associated with testis size in healthy young men. J Clin Sleep Med. 2018;14(10):1757–64. 10.5664/jcsm.7390. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Anawalt BD, Matsumoto AM. Aging and androgens: physiology and clinical implications. Rev Endocr Metab Disord. 2022;23(6):1123–37. 10.1007/s11154-022-09765-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Fukai S, Akishita M, Miyao M, Ishida K, Toba K, Ouchi Y. Age-related changes in plasma androgen levels and their association with cardiovascular risk factors in male Japanese office workers. Geriatr Gerontol Int. 2010;10(1):32–9. 10.1111/j.1447-0594.2009.00552.x. [DOI] [PubMed] [Google Scholar]
- 67.Ogoniak L, Sandmann S, Varghese J, Busch AS. 8039 role of genetics in the Age-Related testosterone decline in men: A UK biobank study. J Endocr Soc. 2024;8(Supplement1). bvae163.1665. [DOI] [PubMed]
- 68.Tibblin G, Adlerberth A, Lindstedt G, Björntorp P. The Pituitary-Gonadal Axis and health in elderly men: A study of men born in 1913. Diabetes. 1996;45(11):1605–9. 10.2337/diab.45.11.1605. [DOI] [PubMed] [Google Scholar]
- 69.Patil R, Sontakke T, Biradar A, Nalage D. Zinc: an essential trace element for human health and beyond. Food Health. 2023;5(3):13. 10.53388/FH2023013. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
No datasets were generated or analysed during the current study.
